Literature DB >> 31586546

The Diversification of Cell Death and Immunity: Memento Mori.

Arnaud J Legrand1, Maria Konstantinou1, Emily F Goode1, Pascal Meier2.   

Abstract

Why do cells have so many ways to die? Why does "cellular suicide" exist at all? In the war against pathogens and rogue cells, organisms developed cellular suicide as a last resort. Fighting an evolutionary arms race, cell death pathways have adapted and multiplied to cover the complexity of the foes the immune system faces. In this review, we discuss the different types of cell death, the underlying signaling events, and their unequal ability to trigger an immune response. We also comment on how to use our knowledge of cell death signaling to improve the efficacy of cancer treatment. We argue that cell death is integral to the immune response and acts as a beacon, a second messenger, that guides both immune system and tissue micro-environment to ensure tissue repair and homeostasis. Memento mori-"remember you must die"-as failure to do so opens the way to chronic infection and cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31586546     DOI: 10.1016/j.molcel.2019.09.006

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  40 in total

Review 1.  Immunogenic cell death (ICD)-inducers in non-small-cell lung carcinoma (NSCLC): current knowledge and future perspective.

Authors:  Alireza Kashefizadeh; Hossein Kazemizadeh
Journal:  Clin Transl Oncol       Date:  2022-09-30       Impact factor: 3.340

2.  Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity.

Authors:  Bartosz Wiernicki; Sophia Maschalidi; Jonathan Pinney; Sandy Adjemian; Tom Vanden Berghe; Kodi S Ravichandran; Peter Vandenabeele
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

3.  Characteristics of Prognostic Programmed Cell Death-Related Long Noncoding RNAs Associated With Immune Infiltration and Therapeutic Responses to Colon Cancer.

Authors:  Yan Chen; Yue Zhang; Jiayi Lu; Zhongchen Liu; Shasha Zhao; Mengmei Zhang; Mingzhi Lu; Wen Xu; Fenyong Sun; Qi Wu; Qi Zhong; Zhongqi Cui
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

4.  Identification of pyroptosis related subtypes and tumor microenvironment infiltration characteristics in breast cancer.

Authors:  Guo Huang; Jun Zhou; Juan Chen; Guowen Liu
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

Review 5.  Regulation and Consequences of cGAS Activation by Self-DNA.

Authors:  Christian Zierhut; Hironori Funabiki
Journal:  Trends Cell Biol       Date:  2020-06-13       Impact factor: 20.808

Review 6.  Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer.

Authors:  Elodie Lafont
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

Review 7.  Extracellular Vesicles as Therapeutic Agents for Cardiac Fibrosis.

Authors:  Russell G Rogers; Alessandra Ciullo; Eduardo Marbán; Ahmed G Ibrahim
Journal:  Front Physiol       Date:  2020-05-21       Impact factor: 4.566

Review 8.  The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.

Authors:  Tania Løve Aaes; Peter Vandenabeele
Journal:  Cell Death Differ       Date:  2020-11-19       Impact factor: 15.828

Review 9.  Current Prospects for Treatment of Solid Tumors via Photodynamic, Photothermal, or Ionizing Radiation Therapies Combined with Immune Checkpoint Inhibition (A Review).

Authors:  Sanjay Anand; Timothy A Chan; Tayyaba Hasan; Edward V Maytin
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-10

10.  Indirect regulation of HMGB1 release by gasdermin D.

Authors:  Allen Volchuk; Anna Ye; Leon Chi; Benjamin E Steinberg; Neil M Goldenberg
Journal:  Nat Commun       Date:  2020-09-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.